Barbara A. Goff
About
In The Last Decade
Barbara A. Goff
223 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Reproductive Medicine 5.4k
- Obstetrics and Gynecology 3.4k
- Surgery 2.6k
- Oncology 2.4k
- Molecular Biology 1.4k
Countries citing papers authored by Barbara A. Goff
This map shows the geographic impact of Barbara A. Goff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Goff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Goff more than expected).
Fields of papers citing papers by Barbara A. Goff
This network shows the impact of papers produced by Barbara A. Goff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Goff. The network helps show where Barbara A. Goff may publish in the future.
Co-authorship network of co-authors of Barbara A. Goff
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Goff. A scholar is included among the top collaborators of Barbara A. Goff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Goff. Barbara A. Goff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 20 | |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 17 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 9 | |
| 10 | 27 | |
| 11 | OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer breakdown → | 970 |
| 12 | 4 | |
| 13 | 31 | |
| 14 | 60 | |
| 15 | 20 | |
| 16 | 7 | |
| 17 | 258 | |
| 18 | 304 | |
| 19 | Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer. | 28 |
| 20 | Recurrent ovarian granulosa cell tumor: role of combination chemotherapy with report of a long-term response to a cyclophosphamide, doxorubicin and cisplatin regimen. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.